Your Article Summary
See Latest ArticlesPrescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09
Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk.
Methods- Review of evidence for/against statin use in nonalcoholic fatty liver disease
- Statins are widely prescribed, with a significant role in reducing cardiovascular risk
- Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
- Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
- Guidelines advising against statin use in this setting should be reviewed
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Premature Aortic Atherosclerosis in Systemic Lupus Erythematosus: A Controlled Transesophageal Echocardiographic Study
Journal of Rheumatology, 12/08/09
Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease
Nutrition, Metabolism & Cardiovascular Diseases, 12/08/09
Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials
Nutrition, Metabolism & Cardiovascular Diseases, 12/07/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease
Evidence-Based Medicine, 12/07/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease
Clinical Therapeutics, 12/07/09